FDNA, the maker of Face2Gene, believes that scientific advances are best achieved through collaborations.

We are proud to make our proprietary facial analysis, deep phenotyping, and genetic variant prioritization technologies available to our scientific partners – free of charge. Examples of partners include:

  • Genetic clinics
  • Research and academic institutes
  • Diagnostic labs
  • Pharmaceutical companies
  • Patient support groups


FDNA grants research partners:

  • The free use of the core technology powering Face2Gene
  • The support of a dedicated research team that will work with your team to draft grant proposals and IRB applications and manuscripts
  • Access to tens-of-thousands of curated and annotated data-points
  • Full authorship rights

See examples of publications resulting from recent collaborations.

If you are interested in collaborating with us, we invite you to apply to one of the open research programs below, or contact us to inquire about other types of collaborations.

FEATURED: PEDIA Phase 2 Study: Solving Syndromes of Unknown Molecular Cause

Prioritization of Exome Data by Image Analysis. Dr. Peter Krawitz, Charité (in conjunction with GeneTalk and FDNA).

Learn More

Give a Face to a Syndrome

  • Discover new facial gestalts for known syndromes and mutations
  • Group and distinguish between cohorts based on automated facial analysis
  • Identify distinct and characteristic facial features associated specifically with mutations within a single syndrome
  • Identify syndrome facial gestalts for different age groups, genders and ethnicities


Phenotype-Genotype Correlation

  • Identify relationships between phenotypic traits and genotypes
  • Discover new gene-related phenotypes
  • Identify new variant prioritization approaches
  • Quantify the impact of genotypes on phenotypes


Clinical Case Studies

  • Publish unique cases in the London Medical Database (LMD) or other publications
  • Discover new phenotypes for existing syndromes
  • Report how annotated features and gestalt scores help in gene variant prioritization and the diagnosis of unique cases

Research is subject to acceptance of our  Research Terms & Conditions

The Face2Gene User Community

  • Using Face2Gene to reference all my department’s cases, share information with my colleagues and quickly look up relevant information in the London Medical Databases Online saves me hours of work every week and allows me to focus on my patients.

    Dr. Ibrahim Akalin

    Assoc. Prof. Ibrahim Akalin, MD, Medical Geneticist from the Istanbul Medeniyet University, Istanbul, Turkey

  • FDNA’s game-changing technology introduces an objective computer-aided dimension to the “art of dysmorphology”, transforming the analysis into an evidence-based science.

    Dr. Michael R. Hayden

    Chairman of FDNA’s Scientific Advisory Board & Steering Committee and Editor in Chief of Clinical Genetics

  • FDNA is developing technology that has the potential to help so many physicians and families by bringing them closer to a diagnosis- there are literally millions of individuals with unusual features around the world that lack a diagnosis and therefore lack information on natural history, recurrence risk and prevention of known complications.

    Dr. Judith G. Hall

    Professor Emerita of Pediatrics & Medical Genetics UBC & Children's and Women's Health Centre of BC

  • FDNA has been “right on the money”, providing me with relevant, accurate and insightful information for differential diagnoses.

    Dr. Cynthia J.R. Curry

    Professor of Pediatrics UCSF, Adjunct Professor of Pediatrics Stanford

  • I am excited to be a part of the FDNA community, promoting broad information sharing with my peers to amplify the scientific and clinical value of our community’s accumulated knowledge for the purpose of efficiently diagnosing individuals with rare genetic disorders.

    Dr. Karen W. Gripp

    Chief, Division of Medical Genetics A.I. duPont Hospital for Children

  • FDNA's idea of incorporating several dysmorphology resources (OMIM, GeneReviews), supported by their visual analytic technology, will be able to improve researching of genetic syndromes - all within a single mobile app.

    Dr. Chad Haldeman-Englert

    Assistant Professor Pediatrics at Mission Fullerton Genetics

  • Given the advancement of visual analytical technology, it’s about time Dysmorphology is supported with computational capabilities and moving this to mobile support, is simply the next logical step.

    Dr. Chanika Phornphutkul

    Associate Professor of Pediatrics Director, Division of Human Genetics Department of Pediatrics Warren Alpert Medical School of Brown University

  • Having an archive of cases easily accessible from my mobile device anytime and anywhere is a long-time unmet need.

    Dr. Lynne Bird

    Rady Children's Specialists of San Diego

  • FDNA's solution is a huge leap forward for dysmorphology. It saves me significant time when I’m evaluating patients in my clinic and provides me with insightful tools that help me generate a differential diagnosis.

    Dr. David A. Chitayat

    Head of the Prenatal Diagnosis and Medical Genetics Program at Mount Sinai Hospital, Toronto

  • Shortly after learning about Face2Gene, I’ve started to incorporate this amazing tool into my workflow. Soon enough, Face2Gene’s analysis flushed out references that I would not have considered for several of my patients, which turned out to be their correct diagnosis

    Dr. Zvi U. Borochowitz

    Chairman (Retired) of The Simon Winter Institute for Human Genetics at Bnai-Zion Medical Center, Technion-Rappaport Faculty of Medicine

  • The Unknown Forum from Face2Gene is a great community platform for exchanging opinions regarding undiagnosed cases. It is straightforward to use and safe for exchange of medical data, thanks to the efforts of its developers and to the involvement of geneticists worldwide.

    Dr. Oana Moldovan

    Clinical Geneticist at the Hospital Santa Maria, CHLN, Lisbon, Portugal